LIMAA Technologies

About:

LIMAA develops a fully automated tissue preserving end-to-end histopathology platform for clinical use.

Website: https://www.limaa-technologies.com

Top Investors: Projektträger Jülich, Forschungszentrum Jülich

Description:

LIMAA develops a fully automated tissue preserving end-to-end histopathology platform for clinical use. This first of its kind platform allows to analyze entire tissue biospecimens in 2D and 3D without embedding or slicing while the tissue is not consumed. Preserved tissue samples are used for downstream applications leading to the unique opportunity to integrate multiplex biomarker visualization of entire tissue samples, genomics and AI guided decision making in every routine sample - no matter what sample size.

Total Funding Amount:

1.32M EUR

Headquarters Location:

Founded Date:

2022-01-01

Founders:

Camila Tomikawa, Fabian Mohr, Mélanie Guenther, René Hägerling

Number of Employees:

1-10

Last Funding Date:

2024-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai